nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—Doxycycline—MMP8—pharynx cancer	0.0397	1	CrCbGaD
Minocycline—CASP3—tongue—pharynx cancer	0.0364	0.0651	CbGeAlD
Minocycline—CYCS—mouth—pharynx cancer	0.0286	0.0511	CbGeAlD
Minocycline—CASP3—mouth—pharynx cancer	0.0245	0.0438	CbGeAlD
Minocycline—CYCS—neck—pharynx cancer	0.0244	0.0437	CbGeAlD
Minocycline—CASP3—Apoptotic cleavage of cell adhesion proteins—CDH1—pharynx cancer	0.0222	0.0554	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—MMP8—pharynx cancer	0.022	0.0549	CbGpPWpGaD
Minocycline—MMP9—Activation of Matrix Metalloproteinases—MMP8—pharynx cancer	0.0209	0.0522	CbGpPWpGaD
Minocycline—CASP3—neck—pharynx cancer	0.0209	0.0374	CbGeAlD
Minocycline—IL1B—mouth—pharynx cancer	0.0195	0.035	CbGeAlD
Minocycline—CYCS—brainstem—pharynx cancer	0.0187	0.0334	CbGeAlD
Minocycline—MMP9—Collagen degradation—MMP8—pharynx cancer	0.0182	0.0455	CbGpPWpGaD
Minocycline—CASP1—epithelium—pharynx cancer	0.0173	0.0309	CbGeAlD
Minocycline—CASP3—parotid gland—pharynx cancer	0.017	0.0305	CbGeAlD
Minocycline—CYCS—epithelium—pharynx cancer	0.0166	0.0297	CbGeAlD
Minocycline—MMP9—mouth—pharynx cancer	0.0163	0.0291	CbGeAlD
Minocycline—CASP3—brainstem—pharynx cancer	0.016	0.0286	CbGeAlD
Minocycline—CASP1—trachea—pharynx cancer	0.0153	0.0273	CbGeAlD
Minocycline—CASP3—epithelium—pharynx cancer	0.0142	0.0255	CbGeAlD
Minocycline—MMP9—neck—pharynx cancer	0.0139	0.0249	CbGeAlD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0133	0.0332	CbGpPWpGaD
Minocycline—CASP1—lymphoid tissue—pharynx cancer	0.0133	0.0238	CbGeAlD
Minocycline—CYCS—lymphoid tissue—pharynx cancer	0.0128	0.0229	CbGeAlD
Minocycline—IL1B—brainstem—pharynx cancer	0.0128	0.0228	CbGeAlD
Minocycline—CASP3—trachea—pharynx cancer	0.0126	0.0225	CbGeAlD
Minocycline—CASP1—spinal cord—pharynx cancer	0.0121	0.0216	CbGeAlD
Minocycline—CYCS—spinal cord—pharynx cancer	0.0116	0.0208	CbGeAlD
Minocycline—IL1B—epithelium—pharynx cancer	0.0114	0.0203	CbGeAlD
Minocycline—CASP3—lymphoid tissue—pharynx cancer	0.011	0.0196	CbGeAlD
Minocycline—CASP1—head—pharynx cancer	0.0107	0.0192	CbGeAlD
Minocycline—CYCS—head—pharynx cancer	0.0103	0.0184	CbGeAlD
Minocycline—CASP3—spinal cord—pharynx cancer	0.00994	0.0178	CbGeAlD
Minocycline—VEGFA—trachea—pharynx cancer	0.00989	0.0177	CbGeAlD
Minocycline—MMP9—epithelium—pharynx cancer	0.00947	0.0169	CbGeAlD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.00923	0.023	CbGpPWpGaD
Minocycline—CASP3—head—pharynx cancer	0.00883	0.0158	CbGeAlD
Minocycline—IL1B—lymphoid tissue—pharynx cancer	0.00876	0.0157	CbGeAlD
Minocycline—CASP3—Apoptotic cleavage of cellular proteins—CDH1—pharynx cancer	0.00824	0.0205	CbGpPWpGaD
Minocycline—IL1B—spinal cord—pharynx cancer	0.00794	0.0142	CbGeAlD
Minocycline—VEGFA—spinal cord—pharynx cancer	0.00781	0.014	CbGeAlD
Minocycline—CASP1—lymph node—pharynx cancer	0.0075	0.0134	CbGeAlD
Minocycline—MMP9—lymphoid tissue—pharynx cancer	0.0073	0.0131	CbGeAlD
Minocycline—CYCS—lymph node—pharynx cancer	0.00722	0.0129	CbGeAlD
Minocycline—IL1B—head—pharynx cancer	0.00706	0.0126	CbGeAlD
Minocycline—CASP3—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—pharynx cancer	0.00684	0.017	CbGpPWpGaD
Minocycline—MMP9—spinal cord—pharynx cancer	0.00662	0.0118	CbGeAlD
Minocycline—CASP3—Apoptotic execution phase—CDH1—pharynx cancer	0.00641	0.016	CbGpPWpGaD
Minocycline—CASP3—lymph node—pharynx cancer	0.00618	0.0111	CbGeAlD
Minocycline—MMP9—head—pharynx cancer	0.00588	0.0105	CbGeAlD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—TP53—pharynx cancer	0.00586	0.0146	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—CDH1—pharynx cancer	0.00585	0.0146	CbGpPWpGaD
Minocycline—ALOX5—lymphoid tissue—pharynx cancer	0.00577	0.0103	CbGeAlD
Minocycline—CASP3—Extracellular matrix organization—MMP8—pharynx cancer	0.00557	0.0139	CbGpPWpGaD
Minocycline—CYCS—Intrinsic Pathway for Apoptosis—TP53—pharynx cancer	0.00502	0.0125	CbGpPWpGaD
Minocycline—IL1B—lymph node—pharynx cancer	0.00494	0.00884	CbGeAlD
Minocycline—VEGFA—lymph node—pharynx cancer	0.00486	0.00869	CbGeAlD
Minocycline—CASP3—Copper homeostasis—CCND1—pharynx cancer	0.00478	0.0119	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—CCND1—pharynx cancer	0.00478	0.0119	CbGpPWpGaD
Minocycline—ALOX5—head—pharynx cancer	0.00465	0.00831	CbGeAlD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—CCND1—pharynx cancer	0.00462	0.0115	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—CCND1—pharynx cancer	0.00436	0.0109	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—pharynx cancer	0.00436	0.0109	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—CDH1—pharynx cancer	0.00432	0.0108	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00417	0.0104	CbGpPWpGaD
Minocycline—MMP9—lymph node—pharynx cancer	0.00412	0.00736	CbGeAlD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—TP53—pharynx cancer	0.00405	0.0101	CbGpPWpGaD
Minocycline—CASP3—Intrinsic Pathway for Apoptosis—TP53—pharynx cancer	0.00405	0.0101	CbGpPWpGaD
Minocycline—CASP3—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—pharynx cancer	0.004	0.00997	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP8—pharynx cancer	0.00387	0.00964	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—CCND1—pharynx cancer	0.00386	0.00962	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—EGFR—pharynx cancer	0.00384	0.00958	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00374	0.00934	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—CCND1—pharynx cancer	0.00373	0.00929	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—TP53—pharynx cancer	0.0036	0.00897	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—EGFR—pharynx cancer	0.00342	0.00852	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CDH1—pharynx cancer	0.00332	0.00827	CbGpPWpGaD
Minocycline—ALOX5—lymph node—pharynx cancer	0.00326	0.00582	CbGeAlD
Minocycline—IL1B—Leptin signaling pathway—CCND1—pharynx cancer	0.00323	0.00805	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—EGFR—pharynx cancer	0.00318	0.00792	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pharynx cancer	0.00315	0.00786	CbGpPWpGaD
Minocycline—CASP3—Copper homeostasis—TP53—pharynx cancer	0.00315	0.00785	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—TP53—pharynx cancer	0.00315	0.00785	CbGpPWpGaD
Minocycline—SLC22A8—head—pharynx cancer	0.00314	0.00562	CbGeAlD
Minocycline—CYCS—p75(NTR)-mediated signaling—TP53—pharynx cancer	0.00311	0.00776	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TP53—pharynx cancer	0.00311	0.00775	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—EGFR—pharynx cancer	0.0031	0.00773	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—pharynx cancer	0.00309	0.0077	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—TP53—pharynx cancer	0.00304	0.00758	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.00291	0.00727	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.0029	0.00722	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—TP53—pharynx cancer	0.00287	0.00716	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TP53—pharynx cancer	0.00279	0.00696	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by TCPTP—EGFR—pharynx cancer	0.00279	0.00695	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00273	0.00681	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—CDH1—pharynx cancer	0.00268	0.00667	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—pharynx cancer	0.00266	0.00663	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00264	0.00659	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.00263	0.00657	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—CCND1—pharynx cancer	0.00262	0.00652	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—TP53—pharynx cancer	0.00254	0.00633	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—TP53—pharynx cancer	0.00251	0.00626	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.00249	0.00622	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00249	0.00622	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—CCND1—pharynx cancer	0.00248	0.00619	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—EGFR—pharynx cancer	0.00246	0.00613	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—TP53—pharynx cancer	0.00245	0.00612	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—pharynx cancer	0.00236	0.00587	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pharynx cancer	0.00235	0.00586	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CNDP2—pharynx cancer	0.00226	0.00563	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—pharynx cancer	0.00225	0.00562	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—CCND1—pharynx cancer	0.00225	0.0056	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—EGFR—pharynx cancer	0.00221	0.0055	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—EGFR—pharynx cancer	0.00215	0.00536	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—pharynx cancer	0.00215	0.00535	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00213	0.0053	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—EGFR—pharynx cancer	0.00207	0.00516	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—pharynx cancer	0.00207	0.00515	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ADH7—pharynx cancer	0.00204	0.00509	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—pharynx cancer	0.00204	0.00509	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00204	0.00508	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.00201	0.00502	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—EGFR—pharynx cancer	0.00195	0.00485	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ADH1B—pharynx cancer	0.00179	0.00446	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—pharynx cancer	0.00178	0.00445	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—EGFR—pharynx cancer	0.00176	0.00439	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—CDH1—pharynx cancer	0.00175	0.00436	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—pharynx cancer	0.00172	0.0043	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CCND1—pharynx cancer	0.00172	0.0043	CbGpPWpGaD
Minocycline—CYCS—Metabolism—B4GALT5—pharynx cancer	0.00171	0.00426	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00169	0.00421	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00165	0.00411	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—pharynx cancer	0.00164	0.00408	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—pharynx cancer	0.00163	0.00406	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.00162	0.00405	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.0016	0.00399	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.00159	0.00396	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—pharynx cancer	0.00156	0.0039	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—pharynx cancer	0.00148	0.00369	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00147	0.00366	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD79A—pharynx cancer	0.00142	0.00353	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CNDP2—pharynx cancer	0.00139	0.00347	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—pharynx cancer	0.00135	0.00337	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00134	0.00335	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00133	0.00331	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00132	0.0033	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—pharynx cancer	0.00131	0.00328	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ADH7—pharynx cancer	0.00126	0.00314	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—pharynx cancer	0.00123	0.00307	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00123	0.00306	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CDH1—pharynx cancer	0.00121	0.00303	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00117	0.00292	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—pharynx cancer	0.00114	0.00283	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—pharynx cancer	0.00112	0.00278	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00111	0.00277	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ADH1B—pharynx cancer	0.0011	0.00275	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—pharynx cancer	0.00106	0.00265	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—B4GALT5—pharynx cancer	0.00105	0.00263	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—pharynx cancer	0.00102	0.00255	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00102	0.00254	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000963	0.0024	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—pharynx cancer	0.000959	0.00239	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—pharynx cancer	0.000885	0.00221	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000809	0.00202	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—pharynx cancer	0.000802	0.002	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000798	0.00199	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—pharynx cancer	0.000792	0.00197	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDH1—pharynx cancer	0.000789	0.00197	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00067	0.00167	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—pharynx cancer	0.000603	0.0015	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—pharynx cancer	0.000523	0.0013	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—pharynx cancer	0.000517	0.00129	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDH1—pharynx cancer	0.000493	0.00123	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—pharynx cancer	0.000461	0.00115	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—pharynx cancer	0.00043	0.00107	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—pharynx cancer	0.000373	0.00093	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—pharynx cancer	0.000307	0.000766	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—pharynx cancer	0.000288	0.000719	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—pharynx cancer	0.000263	0.000655	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—pharynx cancer	0.000206	0.000513	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—pharynx cancer	0.000182	0.000454	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—pharynx cancer	0.000173	0.000431	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—pharynx cancer	0.000158	0.000394	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—pharynx cancer	0.000143	0.000356	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—pharynx cancer	0.000124	0.000309	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—pharynx cancer	0.00012	0.000299	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—pharynx cancer	0.000104	0.00026	CbGpPWpGaD
